Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $9.68B | 7.30% | 5.70% | -1.34% | -1.60% | 0.28 | 2.86 | 98.30% | 6.10% | -1.16% | ||
| LQDA | LIQUIDIA CORP | $7.02B | 46.80% | 7.10% | 20.74% | 26.40% | 2.70 | 2.22 | 91.80% | 7.70% | 18.13% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $41.76B | 98.30% | 11.80% | 23.01% | 17.20% | 3.77 | 3.13 | 80.80% | 13.50% | 20.29% | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.43B | 735.00% | 3.20% | 14.87% | 13.00% | 29.13 | 2.12 | 85.90% | 3.80% | 12.92% | ||
| KRYS | KRYSTAL BIOTECH INC | $11.06B | 19.30% | 17.60% | 16.08% | 27.50% | 0.09 | 9.46 | 94.20% | 53.90% | 49.68% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.96B | 13.30% | 9.90% | 15.85% | 25.20% | 0.36 | 3.79 | 89.30% | 9.70% | 14.06% | ||
| HALO | HALOZYME THERAPEUTICS INC | $9.42B | 126.30% | 14.70% | 22.62% | 21.60% | 11.17 | 2.76 | 82.80% | 23.10% | 34.64% | ||
| VCEL | VERICEL CORP | $2.40B | 6.40% | 4.60% | 5.24% | 5.50% | 0.36 | 5.18 | 74.80% | 7.30% | 7.86% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.40B | 4.40% | 3.40% | 5.24% | 7.10% | 0.38 | 5.81 | 76.50% | 8.30% | 12.60% | ||
| RPRX | ROYALTY PHARMA PLC | $33.27B | 8.50% | 4.30% | 6.03% | 4.50% | 0.99 | 2.66 | 100.00% | 33.90% | 47.67% | ||
| ADMA | ADMA BIOLOGICS INC | $2.07B | 39.00% | 27.40% | 36.10% | 39.40% | 0.70 | 6.95 | 61.30% | 32.40% | 41.89% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $826.43M | 81.30% | 45.60% | 60.94% | 67.80% | 0.35 | 4.89 | 86.10% | 101.60% | 115.40% | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.28B | 0.70% | 0.30% | -0.39% | -0.50% | 1.62 | 2.04 | 88.00% | 0.70% | -0.85% | ||
| ASND | ASCENDIS PHARMA A | $17.05B | -5,435.60% | 35.80% | 7.06% | 7.60% | 3.11 | 1.00 | 89.00% | 57.30% | 7.15% | ||
| TGTX | TG THERAPEUTICS INC | $8.16B | 87.40% | 42.80% | 11.17% | 13.50% | 1.62 | 5.81 | 83.10% | 66.00% | 21.41% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.16B | 17.20% | 12.00% | 20.07% | 48.50% | 0.40 | 3.58 | 76.50% | 16.20% | 23.54% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $6.40B | 16.20% | 11.10% | 12.77% | 15.60% | 0.54 | 21.28 | 95.30% | 55.90% | 69.40% | ||
| TECH | BIO-TECHNE CORP | $11.09B | 5.50% | 4.30% | 6.49% | 12.30% | 0.22 | 4.49 | 65.00% | 9.00% | 12.86% | ||
| SPRO | SPERO THERAPEUTICS INC | $127.38M | 35.60% | 25.00% | 28.95% | 165.70% | 0.12 | 10.50 | 100.00% | 24.90% | 25.33% | ||
| EXEL | EXELIXIS INC | $14.04B | 40.20% | 30.50% | 45.14% | 46.40% | 0.34 | 3.26 | 96.40% | 35.10% | 42.23% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $134.02B | 23.90% | 17.20% | 22.90% | 31.70% | 0.37 | 3.02 | 86.20% | 35.50% | 42.36% | ||
| NAGE | NIAGEN BIOSCIENCE INC | $273.18M | 25.40% | 18.20% | 21.52% | 118.30% | 0.39 | 4.61 | 64.30% | 14.30% | 15.10% | ||
| UTHR | UNITED THERAPEUTICS CORP | $23.60B | 19.20% | 17.20% | 26.58% | 30.40% | 0.14 | 4.79 | 86.60% | 40.60% | 51.27% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.85B | 23.70% | 20.70% | 29.20% | 272.30% | 0.13 | 7.10 | 86.00% | 37.10% | 49.66% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $68.59B | 14.30% | 11.10% | 14.55% | 15.20% | 0.30 | 3.57 | 84.50% | 29.60% | 34.89% | ||
| VCYT | VERACYTE INC | $4.55B | 6.90% | 6.30% | 6.57% | 42.50% | 0.07 | 9.31 | 70.90% | 16.20% | 16.75% | ||
| INCY | INCYTE CORP | $23.35B | 29.20% | 21.70% | 30.37% | 79.50% | 0.31 | 3.68 | 92.50% | 26.70% | 33.13% | ||
| SRPT | SAREPTA THERAPEUTICS INC | $2.04B | 4.90% | 1.90% | 0.91% | 0.80% | 1.11 | 4.63 | 62.90% | 3.00% | 1.12% | ||
| MDXG | MIMEDX GROUP INC | $588.34M | 12.90% | 9.70% | 15.10% | 39.70% | 0.27 | 5.40 | 81.00% | 7.90% | 10.24% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.